MEGAN LOCKARD: Open Payments
NPI 1265118087 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,749 in 182 payments from 21 companies in 2025. Trend: 2023 $162 · 2024 $1,621 · 2025 $4,749
Food & beverage: $4,540Education: $210
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 43 | $1,181 |
| ABBVIE INC. | 36 | $571 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $424 |
| UCB, Inc. | 10 | $404 |
| Novartis Pharmaceuticals Corporation | 11 | $347 |
| Arcutis Biotherapeutics, Inc. | 13 | $338 |
| GENZYME CORPORATION | 9 | $307 |
| Lilly USA, LLC | 7 | $229 |
| Regeneron Healthcare Solutions, Inc. | 6 | $182 |
| Janssen Scientific Affairs, LLC | 1 | $145 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Zoryve, ILUMYA, SKYRIZI, RINVOQ, COSENTYX.
Industry payments across IL — which companies pay providers there.
